Smarda J, Lipsick J S
Department of Pathology, Stanford University School of Medicine, California 94305-5324.
Oncogene. 1994 Jan;9(1):237-45.
Myelomonocytic cells transformed by v-Myb or altered forms of c-Myb do not contain the full-length c-Myb protein found in most immature hematopoietic cells. To determine if c-Myb was a dominant inhibitor of v-Myb, we have induced the synthesis of full-length c-Myb in monoblasts transformed by v-Myb. We found that although some morphological changes occurred, the presence of both c-Myb and v-Myb was compatible with cell growth. However, the response to phorbol ester (TPA) was significantly altered by c-Myb. Monoblasts transformed by v-Myb can be induced to differentiate into macrophages by treatment with TPA. This process is accompanied by a significant amount of cell death. However, when c-Myb was made TPA-inducible in these cells, TPA-induced differentiation into macrophages was blocked and cell death was prevented. These results demonstrate a significant difference in the biological effects of v-Myb and c-Myb in transformed myelomonocytic cells.
由v-Myb或c-Myb的变异形式转化而来的髓单核细胞并不含有大多数未成熟造血细胞中存在的全长c-Myb蛋白。为了确定c-Myb是否是v-Myb的显性抑制剂,我们在由v-Myb转化的单核母细胞中诱导了全长c-Myb的合成。我们发现,尽管发生了一些形态学变化,但c-Myb和v-Myb的同时存在与细胞生长是相容的。然而,c-Myb显著改变了对佛波酯(TPA)的反应。用TPA处理可诱导由v-Myb转化的单核母细胞分化为巨噬细胞。这个过程伴随着大量细胞死亡。然而,当在这些细胞中使c-Myb对TPA具有诱导性时,TPA诱导的向巨噬细胞的分化被阻断,细胞死亡也得到了预防。这些结果表明,v-Myb和c-Myb在转化的髓单核细胞中的生物学效应存在显著差异。